MRVI

Maravai LifeSciences Holdings, Inc. Class A Common Stock

7.58

USD

+0.26

+3.55%

Oct 26, 15:59 UTC -4

Closed

After-Market

7.58

0.00

+0.07%

Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI) Earnings

MRVI Earnings Reports

Positive Surprise Ratio

MRVI beat 15 of 23 last estimates.

65%

Next Report

Date of Next Report

Nov 04, 2026

Estimate for Q3 26 (Revenue/ EPS)

$44.44M

-$0.05

Implied change from Q2 26 (Revenue/ EPS)

-13.62%

+150.00%

Implied change from Q3 25 (Revenue/ EPS)

+6.74%

-37.50%

Maravai LifeSciences Holdings, Inc. Class A Common Stock earnings per share and revenue

On Aug 06, 2026, MRVI reported earnings of -0.02 USD per share (EPS) for Q2 26, beating the estimate of -0.04 USD, resulting in a 54.65% surprise. Revenue reached 51.44 million, compared to an expected 49.66 million, with a 3.60% difference. The market reacted with a -0.32% price change (close before vs. close after earnings).

Looking ahead to Q3 26, 11 analysts forecast an EPS of -0.05 USD, with revenue projected to reach 44.44 million USD, implying an increase of 150.00% EPS, and decrease of -13.62% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

Abbott Laboratories

Report Date

Oct 21, 2026 For Q3 26

Estimate

$1.42

Actual

$1.42

Surprise

-0.68%

FAQ

What were Maravai LifeSciences Holdings, Inc. Class A Common Stock's earnings and revenue for the latest quarter Q2 2026?

For Q2 2026, Maravai LifeSciences Holdings, Inc. Class A Common Stock reported EPS of -$0.02, beating estimates by 54.65%, and revenue of $51.44M, 3.6% above expectations.

How did the market react to Maravai LifeSciences Holdings, Inc. Class A Common Stock's Q2 2026 earnings?

The stock price moved down -0.32%, changed from $6.25 before the earnings release to $6.23 the day after.

When is Maravai LifeSciences Holdings, Inc. Class A Common Stock expected to report next?

The next earning report is scheduled for Nov 04, 2026.

What are the forecasts for Maravai LifeSciences Holdings, Inc. Class A Common Stock's next earnings report?

Based on 11 analysts, Maravai LifeSciences Holdings, Inc. Class A Common Stock is expected to report EPS of -$0.05 and revenue of $44.44M for Q3 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.